CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer

Sergey Nikolaevich Novikov, Roman Vladimirovich Novikov, Yurii Olegovich Merezhko, Mariya Yurevna Gotovchikova, Nikolai Dmitrievich Ilin, Yulia Sergeevna Melnik, Sergey Vasilevich Kanaev

Radiation Oncology Journal. 2022;40(3):200-207. Published online 2022 September 30 DOI: https://doi.org/10.3857/roj.2022.00339

A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer

Sergey Nikolaevich Novikov, Roman Vladimirovich Novikov, Yurii Olegovich Merezhko, Mariya Yurevna Gotovchikova, Nikolai Dmitrievich Ilin, Yulia Sergeevna Melnik, Sergey Vasilevich Kanaev

Radiation Oncology Journal. 2022;40(3):200-207

Link1

Link2 Link3

Dose-Escalated Adaptive Image-Guided Radiotherapy Versus Pelvic Irradiation With High-Dose-Rate Brachytherapy Boost for High-Risk Prostate Cancer

Larry L. Kestin, Ovidiu Marina, Michel I. Ghilezan, Chirag Shah, Gary Gustafson, Donald S. Brabbins, Hong Ye, Michelle Wallace, Daniel J. Krauss, Frank A. Vicini, Alvaro A. Martinez

Brachytherapy. 2011;10:S28-S29

Link1 Link2

143 High Dose-Rate (HDR) brachytherapy boost for high risk localized prostate cancer: feasibility and analysis of acute toxicity

Radiotherapy and Oncology. 2003;69:S35

Link1 Link2

Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy

Hideya Yamazaki, Gen Suzuki, Koji Masui, Norihiro Aibe, Daisuke Shimizu, Takuya Kimoto, Ken Yoshida, Satoaki Nakamura, Haruumi Okabe

Cancers. 2021;13(8):1856

Link1

A Comparative Study of Quality of Life in Patients with Low-and Intermediate-Risk Prostate Cancer: Stereotactic Radiotherapy vs. High Dose-Rate Brachytherapy Monotherapy vs. High Dose-Rate Brachytherapy Boost

Joelle Helou, Gerard Morton, Andrea Bezjak, Alex Kiss, Nicole Mittmann, Ananth Ravi, Hans Radiation Oncology Chung, Melanie Davidson, Patrick Cheung, Andrew Loblaw

Brachytherapy. 2018;17(4):S57

Link1 Link2

Dose-Escalated Adaptive Image-Guided Radiotherapy Versus Pelvic Irradiation With High-Dose-Rate Brachytherapy Boost for Intermediate-Risk Prostate Cancer

Ovidiu Marina, Larry L. Kestin, Michel I. Ghilezan, Chirag Shah, Gary Gustafson, Donald S. Brabbins, Hong Ye, Michelle Wallace, Daniel J. Krauss, Frank A. Vicini, Alvaro A. Martinez

Brachytherapy. 2011;10:S30-S31

Link1 Link2

Commentary on “The clinical significance of persistent prostate cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer”

Juanita Crook

Brachytherapy. 2015;14(3):315

Link1 Link2

11 Boost treatment for intermediate and high risk prostate cancer: low dose rate vs. high dose rate

Radiotherapy and Oncology. 2005;75:S5

Link1 Link2

Pelvic External Beam Radiotherapy and High Dose Rate Image Guided Interstitial Brachytherapy Boost for High Risk Prostate Cancer

P. De Ieso, U. Schick, D. Ward, R. Hughes, P. Ostler, P. Hoskin

Clinical Oncology. 2012;24(2):154-155

Link1 Link2

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy

Ting Martin Ma, Oscar Lilleby, Wolfgang A. Lilleby, Amar U. Kishan

Cancers. 2020;12(12):3606

Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Radiat Oncol J has participated in CrossRef Text and Data Mining service since October 29, 2014.